Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis



Rating:

Share or cite this content

Citations should be made in the following way:
B. Trapnell (Cincinnati, United States of America), Y. Inoue (Osaka, Japan), F. Bonella (Essen, Germany), C. Morgan (London, United Kingdom), S. Jouneau (Rennes, France), E. Bendstrup (Aarhus, Denmark), I. Campo (Pavia, Italy), S. Papiris (Athens, Greece), E. Yamaguchi (Aichi, Japan), E. Cetinkaya (Istanbul, Turkey), M. Ilkovich (St. Petersburg, Russian Federation), M. Kramer (Petah Tikva, Israel), M. Veltkamp (Nieuwegein, Netherlands), M. Kreuter (Heidelberg, Germany), T. Baba (Yokohama, Japan), C. Ganslandt (Austin, United States of America), I. Tarnow (Austin, United States of America), G. Waterer (Perth, Australia), T. Jouhikainen (Austin, United States of America). Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis (APAP). 3803

Member's Comments

No comment yet.

Related content which might interest you: Successful treatment of alveolar proteinosis by inhaled GM-CSF and intravenous rituximab Source: International Congress 2014 – ILDs 5 Year: 2014 Effect of Disodium Etidronate in Patient With Pulmonary Alveolar Microlithiasis Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Methylprednisolone pulse therapy in Acute Exacerbations of Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 LATE-BREAKING ABSTRACT: Bosentan in Pulmonary Hypertension associated with Fibrotic Idiopathic Interstitial Pneumonia:A Randomized, Double-Blind, Placebo-controlled Study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study Source: International Congress 2014 – IPF and surroundings Year: 2014 Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015 Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Characterize Idiopathic Pulmonary Fibrosis using Respiratory Oscillometry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Pulmonary Alveolar Microlithiasis: From Diagnosis to Transplant: An Indian Experience Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Inhaled sargramostim and whole lung lavage (WLL) as therapy of autoimmune pulmonary alveolar proteinosis (aPAP) Source: International Congress 2016 – Orphan diseases I Year: 2016 Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 Idiopathic Pulmonary Fibrosis (IPF): Should it be all about the FVC? Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Pirfenidone therapy for patients with progressive idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 3 Year: 2014 Treprostinil pharmacokinetics in rats are extended using inhaled prodrug formulations Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 IPF - Idiopathic Pulmonary Fibrosis Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152 Year: 2019 Inhaled GM-CSF for autoimune pulmonary alveolar proteinosis Source: Short video statement 2020 Year: 2020